{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "North Brunswick",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78446",
      "recalling_firm": "Claris Lifesciences Inc",
      "address_1": "1445 US Highway 130",
      "address_2": "",
      "postal_code": "08902-3100",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0127-2018",
      "product_description": "Ciprofloxacin in Dextrose (5%) Injection, USP 200 mg in 100 mL  5% Dextrose, Rx Only, (2 mg/mL), 100 mL Flexible Bag, Manufactured for: Claris LifeScience Inc. North Brunswick NJ 08902 by Claris Injectables Ltd. Gujarat, India UPC 336000008242 NDC 36000-008-249",
      "product_quantity": "",
      "reason_for_recall": "Superpotent",
      "recall_initiation_date": "20171106",
      "center_classification_date": "20171221",
      "termination_date": "20200420",
      "report_date": "20171227",
      "code_info": "A060192 01/2018;  A060305 02/2018;  A061038 08/2018;  A0A0068 12/2018;  A0A0404  04/2019",
      "more_code_info": ""
    }
  ]
}